Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: Egyesült ÁllamokFázis nélkül

Studies of Brain Function and Course of Illness in Pediatric Bipolar Disorder

A legfontosabb adatok

Ki végzi
National Institute of Mental Health (NIMH)
Hol
Bethesda (Egyesült Államok)A helyszín megnézése
Azonosító
Állapot
Toboroz
Résztvevők
2350 fő, tervezett
Kezdés
2002. jan. 1.
A vizsgálat típusa
Megfigyeléses, 6 csoport
A vizsgált kezelések
  • Lithium
A regiszteradat frissítve
2026. szeptember 23.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

A vizsgálat súlyos hangulati problémákkal élő gyerekeket és tizenéveseket keres (DMDD vagy küszöb alatti DMDD), valamint depressziós vagy ADHD-s gyerekeket, gondozókat és egészséges önkénteseket összehasonlításhoz.

Életkor
7 évtől 85 évig. DMDD-s gyerekek: 7-17 év. Depressziós gyerekek: 11-17 év. ADHD-s gyerekek: 8-17 év.
Nem
Mindkét nem
A betegség stádiuma
A DMDD-s gyerekeknél a mérges, szomorú vagy ingerlékeny hangulat legalább 12 hónapja a napok nagy részén jelen van, súlyos dühkitörésekkel, 10 éves kor előtti kezdettel. A többieknél: major depresszió vagy ADHD.

A részvétel fő kizáró okai

  • A bipoláris zavar jelei, például emelkedett hangulat vagy csökkent alvásigény
  • 70 alatti IQ
  • Terhesség vagy szoptatás
  • Alkohol- vagy droghasználat az elmúlt három hónapban
  • Skizofrénia-típusú betegség, PDD vagy PTSD

A regiszter feltételei, szó szerint

Mind a 14 feltétel megnézéseKevesebb

Ki nem vehet részt

  • Exclusion of caregivers of children and adolescents with DMDD or subthreshold DMDD; 2.1 Have an I.Q. < 70; 2.2 Have any serious medical condition or condition that interferes with participation; 3.2 Healthy Volunteer (Control) Children:; 3.2.1. I.Q. < 70; 3.2.2. Any serious medical condition or condition that interferes with fMRI or MEG/EEG scanning, or fNIRS, pregnant or lactating; 3.2.3. Past or current diagnosis of any anxiety disorder (panic disorder, GAD, Separation Anxiety Disorder, Social Phobia), mood disorder (manic or hypomanic episode, major depression), OCD, PTSD, Conduct Disorder, psychosis, current suicidal ideation, Tourette Disorder, Autism Spectrum Disorder or ADHD; 3.2.4. Substance abuse within two months prior to study participation or present substance abuse; 3.2.5. History of sexual abuse; 3.2.6. Parent or sibling with Bipolar Disorder, recurrent MDD, or any disorder with psychosis; 4.2 Healthy Volunteer Adults:; 4.2.1. IQ< 70; 4.2.2. Pregnant; 4.2.3. Any past or current history of Bipolar Disorder (any manic or hypomanic episode), recurrent MDD, or any disorder with psychosis; 5.3 Exclusion criteria for those with MDD:; 5.3.1 The individual exhibits any of these cardinal bipolar symptoms:; 5.3.1.1 Elevated or expansive mood; 5.3.1.2 Grandiosity or inflated self-esteem; 5.3.1.3 Decreased need for sleep; 5.3.1.4 Increase in goal-directed activity (this can result in the excessive involvement in pleasurable activities that have a high potential for painful consequences); 5.3.1.5. Has BD symptoms in distinct periods lasting more than 1 day; 5.3.2. Meets criteria for schizophrenia, schizophreniform disorder, schizoaffective illness, PDD, or PTSD; 5.3.3. IQ< 70; 5.3.4. The symptoms are due to the direct physiological effects of a drug of abuse, or to a general medical or neurological condition; 5.3.5. Currently pregnant or lactating; 5.3.6. Meets criteria for alcohol or substance abuse with the last three months; 6.2. Exclusion criteria for those with ADHD:; 6.2.1. IQ<70; 6.2.2. Pregnancy; 6.2.3. Ongoing medical illness or neurological disorder other than ADHD; 6.2.4. Any condition that would interfere with the participants' ability to perform research tasks; 6.2.5. Current Major Depression; 6.2.6. Any past or present manic or hypomanic episode
  • 1.3.2. Meets criteria for schizophrenia, schizophreniform disorder, schizoaffective illness, PDD, or PTSD
  • 1.3.4. The symptoms are due to the direct physiological effects of a drug of abuse, or to a general medical or neurological condition
  • 1.3 Exclusion criteria for those with DMDD:
  • 1.3.1 The individual exhibits any of these cardinal bipolar symptoms:
  • 1.3.1.1 Elevated or expansive mood
  • 1.3.1.2 Grandiosity or inflated self-esteem
  • 1.3.1.3 Decreased need for sleep
  • 1.3.1.4 Increase in goal-directed activity (this can result in the excessive involvement in pleasurable activities that have a high potential for painful consequences)
  • 1.3.1.5. Has BD symptoms in distinct periods lasting more than 1 day
  • 1.3.3. IQ< 70
  • 1.3.5. Currently pregnant or lactating
  • 1.3.6. Meets criteria for alcohol or substance abuse with the last three months

Egyéb feltételek

  • INCLUSION CRITERIA:; Inclusion criteria for children with DMDD, subthreshold DMDD:; 1.1.1 Ages 7-17 at the time of recruitment; will be followed in the longitudinal component of the study until age 25; 1.1.2 Abnormal mood (specifically, anger, sadness, and/or irritability), present at least half of the day most days (or at least half the day at least one day per week for subthreshold), and of sufficient severity to be noticeable by people in the child's environment (e.g. parents/caregivers, teachers, peers); 1.1.3 Compared to his/her peers, the child exhibits markedly increased reactivity to negative emotional stimuli that is manifest verbally or behaviorally. For example, the child responds to frustration with extended temper tantrums (inappropriate for age and/or precipitating event), verbal rages, and/or aggression toward people or property. Such events occur, on average, at least three times a week. For subthreshold DMDD such tantrums occur on average at least once per month; 1.1.4 The symptoms in # 1.1.2, and 1.1.3 above are currently present and have been present for at least 12 months without any symptom-free periods exceeding three months; 1.1.5 The onset of symptoms must be prior to age 10 years; 1.1.6 For DMDD the symptoms are severe in at least in one setting (e.g. violent outbursts, assaultiveness at home, school, or with peers) and at least mild (distractibility, intrusiveness) in a second setting. For subthreshold DMDD, there must be evidence of impairment causing distress to the child or to those around him/her in at least one setting; Caregivers of children and adolescents with DMDD or subthreshold DMDD enrolled in 02-M-0021; 2.1.1. Are capable of performing behavioral tasks and/or scanning; 2.1.2. Speaks English; Healthy Volunteer (Control) Children; 3.1.1. Control subjects will be group matched to the patients; 3.1.2. Have an identified primary care physician; 3.1.3. Speaks English; Healthy Volunteer Adults; 4.1.1 Control subjects will be group matched to the patients; 4.1.2. They will have normal physical and neurological examinations by history or checklist; 4.1.3. Have an identified primary care physician; 4.1.4 Speaks English; Children with Major Depressive Disorder (MDD) Inclusion criteria (all must be met):; 5.1.1 Ages 11-17 at the time of recruitment; will be followed in the longitudinal component of the study until age 25; 5.1.2. DSM-IV or DSM-5 Major Depressive Disorder; 5.1.2.1 Five or more of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure; 5.1.2.1.1 Depressed mood most of the day, nearly every day, as indicated by either subjective report (e.g., feeling sad, blue, "down in the dumps," or empty) or observation made by others (e.g., appears tearful or about to cry). (In children and adolescents, this may present as an irritable or cranky, rather than sad, mood.); 5.1.2.1.2 Markedly diminished interest or pleasure in all, or almost all, activities every day, such as no interest in hobbies, sports, or other things the person used to enjoy doing; 5.1.2.1.3. Significant weight loss when not dieting or weight gain (e.g., a change of more than 5 percent of body weight in a month), or decrease or increase in appetite nearly every day; 5.1.2.1.4. Insomnia (inability to get to sleep or difficulty staying asleep) or hypersomnia (sleeping too much) nearly every day; 5.1.2.1.5. Psychomotor agitation (e.g., restlessness, inability to sit still, pacing, pulling at clothes or clothes) or retardation (e.g., slowed speech, movements, quiet talking) nearly every day; 5.1.2.1.6. Fatigue, tiredness, or loss of energy nearly every day (e.g., even the smallest tasks, like dressing or washing, seem difficult to do and take longer than usual); 5.1.2.1.7. Feelings of worthlessness or excessive or inappropriate guilt nearly every day (e.g., ruminating over minor past failings); 5.1.2.1.8. Diminished ability to think or concentrate, or indecisiveness, nearly every day (e.g. appears easily distracted, complains of memory difficulties); 5.1.2.1.9. Recurrent thoughts of death (not just fear of dying), recurrent suicidal ideas without a specific plan, or a suicide attempt or a specific plan for committing suicide; 5.1.2.1.10 Symptoms cause clinically significant distress or impairment in social, occupational/academic, or other important areas of functioning; 5.1.2.1.11. The episode is not attributable to the physiological effects of a substance or to another medical condition; 5.1.3. Youth with MDD who are continuing in research as adults must also be receiving psychiatric care for their MDD, if it is ongoing; Children with Attention-Deficit/Hyperactivity Disorder (ADHD); 6.1.1. Age 8-17; 6.1.2. Currently meets DSM-IV or DSM-5 criteria for ADHD; 6.1.3. Subjects with other primary psychiatric disorders including anxiety disorders, dysthymic disorder, past major depression, oppositional defiant disorder, tic disorders, and the learning, communication, and elimination disorders may be accepted; 6.1.4. Have an identified primary care physician; 6.1.5. Speaks English

Nézd meg, megfelelhetsz-e

Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.

  • 7 és 85 év között vagy?

Helyszínek itt: Egyesült Államok

  • National Institutes of Health Clinical CenterBethesda, Egyesült ÁllamokContact: Melissa A Brotman, Ph.D.Résztvevőt keres

A vizsgálatról

Mit akar kideríteni a vizsgálat

This study seeks to learn more about the symptoms of severe mood dysregulation in children and adolescents ages 7-17. Children and adolescents with severe mood dysregulation (SMD) display chronic anger, sadness, or irritability, as well as hyperarousal (such as insomnia, distractibility, hyperactivity) and extreme responses to frustration (such as frequent, severe temper tantrums). Researchers will describe the moods and behaviors of children with these symptoms and use specialized testing and brain imaging to learn about the brain changes associated with this disorder.

A vizsgálat 6 csoportja

  • Children/adolescents with ADHD

    Kezelés: Lithium

  • Children/Adolescents with DMDD or subthreshold DMDD

    Kezelés: Lithium

  • Children/adolescents with MDD
  • Healthy volunteer adults
  • Healthy volunteer children/adolescents
  • Parents of children/adolescents with DMDD or subthreshold DMDD

    Parents of children/adolescents with DMDD or subthresdhold DMDD

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Characterization and Pathophysiology of Severe Mood and Behavioral Dysregulation in Children and Youth
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 12.
Illeszkedési kérdések
Forrás: NCT00025935: ki vehet részt
A regiszteradat frissítve
2026. szeptember 23.